Physician
Internal Medicine
Dr. Michael J. Bloch, MD
|
|
Give Review
Doctor Michael J. Bloch, MD is an expert in the field of Internal Medicine. He researched medicine at Georgetown University School of Medicine. Georgetown University School of Medicine is ranked 49/84 in Research/PrimaryCare. Michael J. Bloch, MD is a published doctor. He has 67 papers published. The most current publication "Exposure to air pollution increases the incidence of hypertension and diabetes in black women living in los angeles." Michael Bloch accepts Medicare.
Publications
- Exposure to air pollution increases the incidence of hypertension and diabetes in black women living in los angeles.
- What Should be the Target Blood Pressure in Patients With Chronic Kidney Disease? Data From the Kidney Early Evaluation Program.
- NHANES Data Highlight the Clinical Characteristics of Those With Poorly Controlled Hypertension.
- UK Guidelines Call for Routine 24-Hour Ambulatory Blood Pressure Monitoring in All Patients to Make the Diagnosis of Hypertension-Not Ready for Prime Time in the Unite...
- New british guidelines mandate ambulatory blood pressure monitoring to diagnose hypertension in all patients: not ready for prime time in the United States.
- Spironolactone is More Effective Than Eplerenone at Lowering Blood Pressure in Patients With Primary Aldosteronism.
- Analysis of recent papers in hypertension.
- African American patients with hypertensive chronic kidney disease receive no benefit on kidney disease progression from the currently recommended blood pressure goal ...
- Patient self-management improves blood pressure control.
- Treating the black hypertensive in 2010: achieve lower targets while awaiting more definitive evidence.
- In navigator, the angiotensin receptor blocker valsartin modestly reduced the progression to type 2 diabetes but had no effect on cardiovascular events in higher-risk ...
- Combination angiotensin receptor blocker-neutral endopeptidase inhibitor provides additive blood pressure reduction over angiotensin receptor blocker alone.
- Meta-analysis concludes angiotensin receptor blocker use increases the risk of developing cancer: concerns about the science and the message.
- Review of recent literature: Existing kidney disease classification guideline needs to incorporate degree of proteinuria with estimated glomerular filtration rate to m...
- Is there accord in ACCORD? Lower blood pressure targets in type 2 diabetes does not lead to fewer cardiovascular events except for reductions in stroke.
- Intensive blood pressure control in children slows progression of chronic kidney disease.
- Angiotensin receptor blocker use may decrease the incidence and progression of Alzheimer's disease and dementia in older men but the strength of the evidence is questi...
- Percutaneous revascularization of the renal arteries offers no evidence of clinical benefit in patients with atherosclerotic renal artery stenosis--the ASTRAL trial.
- Identifying and managing factors that interfere with or worsen blood pressure control.
- High adherence to antihypertensive therapy is rare but when present is associated with a decreased risk of cardiovascular events.
- A lower blood pressure goal in patients without diabetes lessens the occurrence of left ventricular hypertrophy.
- Largest meta-analysis to date suggests that patients at risk for cardiovascular disease events derive benefit from antihypertensive therapy regardless of baseline bloo...
- Hypertension patients with multiple comorbidities are more likely to have their BP controlled within the VA healthcare system: unfounded concerns about pay-for-perform...
- Prior incarceration is associated with an increased risk for developing hypertension.
- Heart failure in people younger than 50 years is more common in black than white Americans and is closely associated with poorly treated and controlled hypertension: t...
- Analysis of recent papers in hypertension, Jan Basile, MD, Senior Editor.
- Analysis of recent papers in hypertension. Lack of legacy effect with more intensive blood pressure control in the long-term follow-up of the United Kingdom Prospectiv...
- In angiotensin-converting enzyme inhibitor-intolerant individuals, the angiotensin receptor blocker telmisartan does not reduce the incidence of major cardiovascular e...
- Analysis of recent papers in hypertension Jan Basile , MD , Senior Editor.
- Overcoming racial and ethnic disparities in blood pressure control: a patient-centered approach to cross-cultural communication.
- Primary hyperaldosteronism in patients with resistant hypertension may be less prevalent than previously reported: evidence against an epidemic.
- Treating hypertension in the oldest of the old reduces total mortality: results of the Hypertension in the Very Elderly Trial (HYVET).
- Analysis of recent papers in hypertension: a simple office-based tool to predict the development of hypertension.
- Self measurement of blood pressure at home should complement rather than replace office blood pressure management.
- Chronotherapy in patients with chronic kidney disease to reduce nighttime blood pressure--not ready for prime time.
- Cholesterol ester transfer protein inhibition with torcetrapib leads to an increase in cardiovascular events: an effect that is unlikely to be the result of increases ...
- Advance trial supports current recommendations for blood pressure goals and not the use of any specific combination of antihypertensive agents in patients with type 2 ...
- Thresholds for diastolic blood pressure reduction in older patients with isolated systolic hypertension appear to be different depending on the presence or absence of ...
- Development of new-onset diabetes mellitus is associated with an increased risk for cardiac morbidity: the VALUE Trial.
- Number of visits at goal blood pressure is associated with improved cardiovascular outcomes--a post hoc analysis of the INVEST trial.
- Blood pressure reduction appears more important than specific antihypertensive agent used to improve diastolic function.
- AHA scientific statement: new blood pressure targets for high-risk and established coronary artery disease patients.
- Defining the role of angiotensin receptor blocker therapy in Japanese persons with underlying vascular disease: the Jikei Heart Study.
- Spironolactone found effective for patients with resistant hypertension in ASCTT-BPLA.
- Diagnosis and management of renovascular disease and renovascular hypertension.
- Aliskerin, an oral renin inhibitor, in combination with a thiazide diuretic, ace inhibitor, or angiotensin receptor antagonist reduces 24-hour blood pressure and suppr...
- Blood pressure control rates in Spain are further improved using daytime ambulatory measurements than when using conventional office based measurement.
- Comparative effectiveness of medical therapy compared with initial percutaneous intervention in the treatment of atherosclerotic renal artery stenosis.
- British hypertension society recommends that beta-blockers are no longer indicated as initial treatment of hypertension: has the pendulum swung too far?
- Effects of a calcium channel blocker and a statin-based treatment regimen in the Anglo-Scandinavian Cardiac Outcomes Trial.
- Hypertension prevalence increases and hypertension control rates improve in the United States: 2003-2004.
- Do angiotensin receptor antagonists decrease hsCRP independent of blood pressure - and does it matter?
- Correction of thiazide-induced hypokalemia prevents hyperglycemia and incident diabetes mellitus.
- Clinical insights into the diagnosis and management of atherosclerotic renal artery disease.
- Angiotensin-converting enzyme inhibitors found unsafe at any time during pregnancy.
- Short-term treatment of sleep apnea with nocturnal continuous positive airway pressure does not improve blood pressure in patients with well controlled hypertension.
- Partners in lowering cholesterol: comparison of a multidisciplinary educational program, monetary incentives, or usual care in the treatment of dyslipidemia identified...
- Chlorthalidone reduces 24-hour ambulatory systolic blood pressure more than hydrochlorothiazide.
- Analysis of recent papers in hypertension: differences in central aortic blood pressure explain outcome differences in ASCOT: the CAFE substudy; and rimonabant improve...
- Venous thrombosis and conjugated equine estrogen in women without a uterus.
- The presence of hyperlipidemia predicts the future risk of hypertension.
- Routine office blood pressure measurements are often higher than standardized or ambulatory readings.
- Lower levels of microalbuminuria are associated with an increased risk of coronary heart disease and death in hypertensive subjects.
- Analysis of recent papers in hypertension. An angiotensin receptor blocker is more effective than a calcium channel blocker in secondary stroke prevention.
- The diagnosis and management of renovascular disease: a primary care perspective. Part II. Issues in management.
- The diagnosis and management of renovascular disease: a primary care perspective. Part I. Making the diagnosis.
Schools
George Washington University School Of Medicine
New York Presbyterian HospitalWeill Cornell Med Center
New York Presbyterian Hospital
Doctors Specialties
- Internal Medicine
Accepted Insurances
Education
-
New York Presbyterian Hospital - Cornell Campus -
Georgetown University School of Medicine
Drug Facts
| NPI NUMBER | 1508970195 | |
| NPPES Provider LastName | BLOCH | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 895021181 | |
| NPPES Provider State | NV | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 2976.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1508970195 |
| Last Name Of The Provider | BLOCH |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Suat Yasar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas R. Conklin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine J. Goring, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Edwards, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Derrick Moore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sujatha Pitani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ritu V. Dixon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven E. Gerson, DO |
|
|
Dr. Christina C. Calvanese, MD |
|
|
Dr. Ronald F. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard B. Rosen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald Cassidy, MD
This Doctor is OpenDoctor Recommended.
|